Matches in SemOpenAlex for { <https://semopenalex.org/work/W2218213848> ?p ?o ?g. }
- W2218213848 endingPage "704" @default.
- W2218213848 startingPage "697" @default.
- W2218213848 abstract "This study assessed the toxicity and activity of biweekly docetaxel and S-1 combination therapy in elderly patients with advanced gastric cancer.One-hundred and thirteen patients were enrolled: 35 were 75 years old or more. The objective response rate, toxicity, progression-free survival (PFS), and overall survival (OS) were compared.Dose reduction was significantly frequent in the elderly group (24/35 versus 25/78, p<0.001). The overall response rate was 54.9%. Out of these, 18 (15.9%) underwent gastrectomy (13 R0 gastrectomy). The median OS was 17.3 months and the median PFS was 8.0 months. Neutropenia was the most frequently observed hematological toxicity at grade 3 and 4 (34.5%), followed by leukopenia (24.8%). Most non-hematological toxicities were of grade 1 or 2. There were no significant differences in overall response rate, median OS, median PFS, or toxicities between the two groups.This combination offers favourable survival benefits with controllable tolerance for therapy of AGC in the elderly." @default.
- W2218213848 created "2016-06-24" @default.
- W2218213848 creator A5000085626 @default.
- W2218213848 creator A5005685330 @default.
- W2218213848 creator A5011404010 @default.
- W2218213848 creator A5032132419 @default.
- W2218213848 creator A5032925936 @default.
- W2218213848 creator A5034040686 @default.
- W2218213848 creator A5043460153 @default.
- W2218213848 creator A5053513593 @default.
- W2218213848 creator A5053977577 @default.
- W2218213848 creator A5054649255 @default.
- W2218213848 creator A5055509303 @default.
- W2218213848 creator A5059199772 @default.
- W2218213848 creator A5072098895 @default.
- W2218213848 creator A5081749381 @default.
- W2218213848 creator A5088272103 @default.
- W2218213848 creator A5090217118 @default.
- W2218213848 date "2013-02-01" @default.
- W2218213848 modified "2023-10-16" @default.
- W2218213848 title "Biweekly Docetaxel and S-1 combination chemotherapy as first-line treatment for elderly patients with advanced gastric cancer." @default.
- W2218213848 cites W1568315148 @default.
- W2218213848 cites W1848862702 @default.
- W2218213848 cites W1967103434 @default.
- W2218213848 cites W1987059589 @default.
- W2218213848 cites W1992489627 @default.
- W2218213848 cites W2002655750 @default.
- W2218213848 cites W2006376556 @default.
- W2218213848 cites W2006794502 @default.
- W2218213848 cites W2010417228 @default.
- W2218213848 cites W2014387313 @default.
- W2218213848 cites W2037572126 @default.
- W2218213848 cites W2063352978 @default.
- W2218213848 cites W2068225833 @default.
- W2218213848 cites W2073533584 @default.
- W2218213848 cites W2074446473 @default.
- W2218213848 cites W2077902459 @default.
- W2218213848 cites W2095088610 @default.
- W2218213848 cites W2103109288 @default.
- W2218213848 cites W2103892569 @default.
- W2218213848 cites W2116068954 @default.
- W2218213848 cites W2129310383 @default.
- W2218213848 cites W2139248078 @default.
- W2218213848 cites W2158387151 @default.
- W2218213848 cites W2161990928 @default.
- W2218213848 cites W2166691176 @default.
- W2218213848 cites W2171075804 @default.
- W2218213848 cites W2182849032 @default.
- W2218213848 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23393370" @default.
- W2218213848 hasPublicationYear "2013" @default.
- W2218213848 type Work @default.
- W2218213848 sameAs 2218213848 @default.
- W2218213848 citedByCount "0" @default.
- W2218213848 crossrefType "journal-article" @default.
- W2218213848 hasAuthorship W2218213848A5000085626 @default.
- W2218213848 hasAuthorship W2218213848A5005685330 @default.
- W2218213848 hasAuthorship W2218213848A5011404010 @default.
- W2218213848 hasAuthorship W2218213848A5032132419 @default.
- W2218213848 hasAuthorship W2218213848A5032925936 @default.
- W2218213848 hasAuthorship W2218213848A5034040686 @default.
- W2218213848 hasAuthorship W2218213848A5043460153 @default.
- W2218213848 hasAuthorship W2218213848A5053513593 @default.
- W2218213848 hasAuthorship W2218213848A5053977577 @default.
- W2218213848 hasAuthorship W2218213848A5054649255 @default.
- W2218213848 hasAuthorship W2218213848A5055509303 @default.
- W2218213848 hasAuthorship W2218213848A5059199772 @default.
- W2218213848 hasAuthorship W2218213848A5072098895 @default.
- W2218213848 hasAuthorship W2218213848A5081749381 @default.
- W2218213848 hasAuthorship W2218213848A5088272103 @default.
- W2218213848 hasAuthorship W2218213848A5090217118 @default.
- W2218213848 hasConcept C121608353 @default.
- W2218213848 hasConcept C126322002 @default.
- W2218213848 hasConcept C141071460 @default.
- W2218213848 hasConcept C143998085 @default.
- W2218213848 hasConcept C2776694085 @default.
- W2218213848 hasConcept C2777063308 @default.
- W2218213848 hasConcept C2780470880 @default.
- W2218213848 hasConcept C2780873365 @default.
- W2218213848 hasConcept C2781190966 @default.
- W2218213848 hasConcept C29730261 @default.
- W2218213848 hasConcept C71924100 @default.
- W2218213848 hasConcept C90924648 @default.
- W2218213848 hasConceptScore W2218213848C121608353 @default.
- W2218213848 hasConceptScore W2218213848C126322002 @default.
- W2218213848 hasConceptScore W2218213848C141071460 @default.
- W2218213848 hasConceptScore W2218213848C143998085 @default.
- W2218213848 hasConceptScore W2218213848C2776694085 @default.
- W2218213848 hasConceptScore W2218213848C2777063308 @default.
- W2218213848 hasConceptScore W2218213848C2780470880 @default.
- W2218213848 hasConceptScore W2218213848C2780873365 @default.
- W2218213848 hasConceptScore W2218213848C2781190966 @default.
- W2218213848 hasConceptScore W2218213848C29730261 @default.
- W2218213848 hasConceptScore W2218213848C71924100 @default.
- W2218213848 hasConceptScore W2218213848C90924648 @default.
- W2218213848 hasIssue "2" @default.
- W2218213848 hasLocation W22182138481 @default.
- W2218213848 hasOpenAccess W2218213848 @default.
- W2218213848 hasPrimaryLocation W22182138481 @default.